Personensuche
Personensuche
Es wurde 1 Person gefunden.
Anschrift
Hufelandstr. 55
45147 Essen
45147 Essen
Telefon
Telefax
E-Mail
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid : A multicenter case seriesIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), 2025, in pressDOI (Open Access)
-
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation lossIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), 2025, in pressDOI (Open Access)
-
Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signalingIn: Nature Communications, Jg. 16, 2025, Nr. 1, 8928DOI (Open Access)
-
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patientsIn: Frontiers in Immunology, Jg. 16, 2025, 1727312DOI (Open Access)
-
pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapyIn: European Journal of Cancer (EJC), Jg. 220, 2025, 115337DOI (Open Access)
-
Case report: : Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumabIn: Frontiers in Immunology, Jg. 15, 2024, 1369190DOI, Online Volltext (Open Access)
-
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanomaIn: Frontiers in Immunology, Jg. 15, 2024, 1383125DOI (Open Access)
-
Deep learning based histological classification of adnex tumorsIn: European Journal of Cancer (EJC), Jg. 196, 2024, 113431
-
Early versus late response to PD-1-based immunotherapy in metastatic melanomaIn: European Journal of Cancer (EJC), Jg. 210, 2024, 114295DOI (Open Access)
-
High-dose intravenous immunoglobulin co-treatment prolongs time-to-treatment escalation in autoimmune bullous diseases : A monocentric retrospective cohort studyIn: Journal of the European Academy of Dermatology and Venereology, Jg. 38, 2024, Nr. 1, S. e74 – e76DOI (Open Access)
-
Rezidivierend auftretende schmerzhafte Ulzera an den unteren Extremitäten und FlankenIn: Die Dermatologie, Jg. 75, 2024, Nr. 12, S. 976 – 979
-
S1-Guideline Sebaceous CarcinomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 22, 2024, Nr. 5, S. 730 – 747DOI (Open Access)
-
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomasIn: European Journal of Cancer (EJC), Jg. 208, 2024, 114208DOI (Open Access)
-
Applying an artificial intelligence deep learning approach to routine dermatopathological diagnosis of basal cell carcinomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 21, 2023, Nr. 11, S. 1329 – 1337
-
Characterisation and outcome of RAC1 mutated melanomaIn: European Journal of Cancer (EJC), Jg. 183, 2023, S. 1 – 10
-
Clinical, histopathological and molecular features of dedifferentiated melanomas : An EORTC Melanoma Group Retrospective AnalysisIn: European Journal of Cancer (EJC), Jg. 187, 2023, S. 7 – 14DOI (Open Access)
-
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma ADOREG/TRIM : Analysis of the DeCOG prospective multicenter cohort studyIn: eBioMedicine, Jg. 96, 2023, 104774DOI (Open Access)
-
Deep learning detection of melanoma metastases in lymph nodesIn: European Journal of Cancer (EJC), Jg. 188, 2023, S. 161 – 170
-
Exacerbated Psoriasis as a Rare Trigger of Multilocular Pyoderma Gangrenosum : A Case Report of a Rare CoincidenceIn: The International Journal of Lower Extremity Wounds, Jg. 22, 2023, Nr. 1, S. 213 – 215DOI (Open Access)
-
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaIn: Journal for ImmunoTherapy of Cancer, Jg. 11, 2023, Nr. 4, e004150DOI (Open Access)
-
HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistanceIn: Clinical Cancer Research, Jg. 29, 2023, Nr. 15, S. 2894 – 2907
-
Prognostic factors in the primary care of patients with Merkel cell carcinoma : A monocentric cohort study of 108 patients from a tertiary referral centreIn: JEADV Clinical Practice, Jg. 2, 2023, Nr. 4, S. 810 – 818DOI, Online Volltext (Open Access)
-
Regulatory T-cell deficiency leads to features of autoimmune liver disease overlap syndrome in scurfy miceIn: Frontiers in Immunology, Jg. 14, 2023, 1253649DOI (Open Access)
-
Successful therapy of ulcerative morphea with topical application of pimecrolimusIn: Journal of the European Academy of Dermatology and Venereology, Jg. 37, 2023, Nr. 3, S. e325 – e326
-
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas : A retrospective cohort study from five European skin cancer reference centresIn: Journal of the European Academy of Dermatology and Venereology, Jg. 37, 2023, Nr. 5, Special issue on melanoma: Immune check point and BRAF‐MEK inhibitors in melanoma, S. 922 – 931DOI (Open Access)
-
Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical FeaturesIn: Journal of Investigative Dermatology, Jg. 142, 2022, Nr. 11, S. 3110 – 3113.e8
-
COVID-19-getriggerte EEM-artige HautveränderungenIn: Deutsches Ärzteblatt International, Jg. 119, 2022, Nr. 8, S. 131DOI (Open Access)
-
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitorsIn: Journal of the European Academy of Dermatology and Venereology, Jg. 36, 2022, Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, S. 41 – 44DOI (Open Access)
-
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variantsIn: Pigment Cell and Melanoma Research, Jg. 35, 2022, Nr. 6, S. 573 – 586DOI (Open Access)
-
Evaluation of a Deep Learning Approach to Differentiate Bowen’s Disease and Seborrheic KeratosisIn: Cancers, Jg. 14, 2022, Nr. 14, 3518DOI (Open Access)
-
Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient SurvivalIn: Cancers, Jg. 14, 2022, Nr. 9, 2090DOI, Online Volltext (Open Access)
-
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic LesionsIn: Cancers, Jg. 14, 2022, Nr. 17, 4066DOI, Online Volltext (Open Access)
-
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumorsIn: International Journal of Cancer, Jg. 151, 2022, Nr. 9, S. 1542 – 1554DOI (Open Access)
-
Genetic characterization of advanced conjunctival melanoma and response to systemic treatmentIn: European Journal of Cancer (EJC), Jg. 166, 2022, S. 60 – 72
-
Giant congenital melanocytic naevus caused by NRAS Q61K mosaicismIn: JEADV Clinical Practice, Jg. 1, 2022, Nr. 4, S. 416 – 419DOI, Online Volltext (Open Access)
-
Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1In: JCI Insight, Jg. 7, 2022, Nr. 24, e162580DOI (Open Access)
-
Leg ulcers in morphea plaquesIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 20, 2022, Nr. 10, S. 1365 – 1367DOI (Open Access)
-
Management of partial and non-responding cutaneous squamous cell carcinomaIn: Journal of the European Academy of Dermatology and Venereology, Jg. 36, 2022, Nr. S1, S. 29 – 34DOI (Open Access)
-
Pathogenic Autoantibody Derived from Regulatory T Cell‒Deficient Scurfy Mice Targets Type VII Collagen and Leads to Epidermolysis Bullosa Acquisita‒Like Blistering DiseaseIn: Journal of Investigative Dermatology, Jg. 142, 2022, Nr. 3, Part B, S. 980 – 984.e4DOI (Open Access)
-
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell CarcinomaIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 3, S. 396 – 398DOI (Open Access)
-
S2k-Leitlinie zur Diagnostik und Therapie des SchleimhautpemphigoidsIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 20, 2022, Nr. 11, S. 1530 – 1552DOI (Open Access)
-
Successful therapy of disseminated patch-type granuloma annulare with upadacitinib in a patient with rheumatoid arthritisIn: Dermatologic Therapy, Jg. 35, 2022, Nr. 1, e15211DOI (Open Access)
-
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapyIn: European Journal of Cancer (EJC), Jg. 161, 2022, S. 99 – 107DOI, Online Volltext (Open Access)
-
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 ImmunohistochemistryIn: Frontiers in Oncology, Jg. 11, 2021, 725549DOI, Online Volltext (Open Access)
-
Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer : A retrospective analysis of 47 casesIn: European Journal of Cancer (EJC), Jg. 150, 2021, S. 119 – 129
-
Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up : A monocentre studyIn: European Journal of Cancer (EJC), Jg. 154, 2021, S. 167 – 174
-
Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 AntagonistsIn: Acta Dermato-Venereologica, Jg. 101, 2021, Nr. 10, adv00568DOI (Open Access)
-
Differential Effects of Dimethyl Fumarate and Monomethyl Fumarate on Neutrophil Granulocyte and PBMC ApoptosisIn: Journal of Investigative Dermatology, Jg. 141, 2021, Nr. 3, S. 699 – 702.e1DOI (Open Access)
-
Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic MelanomaIn: Frontiers in Oncology, Jg. 11, 2021, 741993DOI, Online Volltext (Open Access)
-
Eosinophilic pustular folliculitis (EPF) in a patient with HIV infectionIn: Infection - A Journal of Infectious Disease, Jg. 49, 2021, Nr. 4, S. 799 – 801DOI (Open Access)
-
Epidermolyse nach Stammzelltransplantation bei einem sechsjährigen Kind – Komplexität der Diagnosefindung und TherapieentscheidungIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 19, 2021, Nr. 6, S. 889 – 891DOI (Open Access)
-
Epidermolysis after stem cell transplantation in a six-year-old child – complexity of diagnosis and therapy decisionIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 19, 2021, Nr. 6, S. 889 – 890DOI (Open Access)
-
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis : A Retrospective Cohort Study of 186 Treatment CyclesIn: Acta Dermato-Venereologica, Jg. 101, 2021, Nr. 5, adv00462DOI (Open Access)
-
Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patientsIn: European Journal of Dermatology (EJD), Jg. 31, 2021, Nr. 5, S. 609 – 615
-
GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular TumorsIn: Frontiers in Genetics, Jg. 12, 2021, 663272DOI, Online Volltext (Open Access)
-
High-resolution three-dimensional imaging for precise staging in melanomaIn: European Journal of Cancer (EJC), Jg. 159, 2021, S. 182 – 193DOI (Open Access)
-
Immunoglobulin M pemphigoidIn: Journal of the American Academy of Dermatology: JAAD, Jg. 85, 2021, Nr. 6, S. 1486 – 1492
-
Kutanes Angiosarkom mit klinischem Bild eines Quincke-ÖdemsIn: Der Hautarzt, Jg. 72, 2021, Nr. 9, S. 801 – 804DOI (Open Access)
-
Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patientsIn: The Journal of Dermatology, Jg. 48, 2021, Nr. 6, S. 835 – 843DOI (Open Access)
-
Metastatic pigmented epithelioid melanocytoma in a 7-year-old femaleIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 19, 2021, Nr. 8, S. 1217 – 1219DOI (Open Access)
-
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphologyIn: European Journal of Cancer (EJC), Jg. 148, 2021, S. 340 – 347DOI, Online Volltext (Open Access)
-
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitorsIn: European Journal of Cancer (EJC), Jg. 159, 2021, S. 113 – 124
-
Rare TERT Promoter Mutations Present in Benign and Malignant Cutaneous Vascular TumorsIn: Dermato, Jg. 1, 2021, Nr. 1, S. 18 – 25DOI (Open Access)
-
Response to comment : Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphologyIn: European Journal of Cancer (EJC), Jg. 157, 2021, S. 514 – 515
-
S1-Leitlinie kutane Angiosarkome : Update 2021In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 19, 2021, Nr. 12, S. 1801 – 1813DOI (Open Access)
-
S1‐Guideline Cutaneous Angiosarcomas : Update 2021In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 19, 2021, Nr. 12, S. 1801 – 1812DOI (Open Access)
-
Bräunliche Papeln, Pachydermie und Sklerose mit massivem PruritusIn: Der Hautarzt, Jg. 71, 2020, Nr. 1, S. 78 – 80
-
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy : Increased rate and mimicker of metastasisIn: European Journal of Cancer (EJC), Jg. 131, 2020, S. 18 – 26
-
Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses : A prospective, randomized and rater-blinded study (ACTICAP)In: Journal of the European Academy of Dermatology and Venereology, Jg. 34, 2020, Nr. 12, S. E844 – E846
-
Fatal swelling of the groin – Clear cell sarcoma : A rare but important differential diagnosis to malignant melanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 18, 2020, Nr. 10, S. 1165 – 1168DOI (Open Access)
-
GNAQ and GNA11 mutant nonuveal melanoma : A subtype distinct from both cutaneous and uveal melanomaIn: British Journal of Dermatology: BJD, Jg. 183, 2020, Nr. 5, S. 928 – 939DOI (Open Access)
-
Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment : A case reportIn: Cephalalgia, Jg. 40, 2020, Nr. 11, S. 1255 – 1260DOI, Online Volltext (Open Access)
-
Clinical and genetic analysis of melanomas arising in acral sitesIn: European Journal of Cancer (EJC), Jg. 119, 2019, S. 66 – 76DOI (Open Access)
-
Disseminated emergomycosis in a person with HIV infection, UgandaIn: Emerging Infectious Diseases (EID), Jg. 25, 2019, Nr. 9, S. 1750 – 1751DOI (Open Access)
-
Frequent Occurrence of NRAS and BRAF Mutations in Human Acral NaeviIn: Cancers, Jg. 11, 2019, Nr. 4, S. 546DOI, Online Volltext (Open Access)
-
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanomaIn: European Journal of Cancer (EJC), Jg. 119, 2019, S. 18 – 29
-
Scurfy mice develop features of connective tissue disease overlap syndrome and mixed connective tissue disease in the absence of regulatory T cellsIn: Frontiers in Immunology, Jg. 10, 2019, S. 881DOI (Open Access)
-
Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipientsIn: British Journal of Dermatology: BJD, Jg. 179, 2018, Nr. 2, S. 405 – 412
-
Brownish-yellowish plaque on the penis shaftIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 16, 2018, Nr. 1, S. 104 – 107
-
Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione- and superoxide-dependent mannerIn: British Journal of Dermatology: BJD, Jg. 178, 2018, Nr. 1, S. 207 – 214DOI (Open Access)
-
Long persistence of tumour necrosis factor-α antagonist-induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects : a case study of 14 patients with psoriasisIn: British Journal of Dermatology: BJD, Jg. 178, 2018, Nr. 1, S. e9 – e10
-
NF1 mutations in conjunctival melanomaIn: British Journal of Cancer (BJC), Jg. 118, 2018, Nr. 9, S. 1243 – 1247DOI (Open Access)
-
Rapidly growing verrucous axillary tumors, multiple erosions, pustules, and cheilitisIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 16, 2018, Nr. 10, S. 1269 – 1272
-
Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous diseaseIn: The Journal of Allergy and Clinical Immunology, Jg. 142, 2018, Nr. 6, S. 1831 – 1842.e7
-
Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgEIn: Journal of Dermatological Science, Jg. 87, 2017, Nr. 3, S. 309 – 311
-
Diagnostics of autoimmune bullous diseases in German dermatology departmentsIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 10, 2012, Nr. 7, S. 492 – 500
-
Deciphering unresectable in-transit metastasis in melanoma : Multi-modal and longitudinal insightsIn: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S736
-
The PD-L1 Expression predicts the Outcome of anti-PD-1/PD-L1-based Immune Checkpoint Therapy in Patients with metastatic Merkel Cell CarcinomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 17 – 18
-
Außergewöhnlicher Therapiebenefit von Imatinib bei cKIT-mutiertem Schleimhautmelanom mit nachfolgendem KIT-Mutationsverlust
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21 – 22DOI (Open Access) -
Die PD-L1-Expression im Tumor prognostiziert je nach Art des untersuchten Gewebes das Outcome einer Anti-PD-1-basierten Immuntherapie bei metastasiertem Melanom
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 27 – 28DOI (Open Access) -
Etablierung eines Mustererkennungsalgorithmus zur histologischen Detektion von Melanommetastasen im Schildwächterlymphknoten
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 20 – 21DOI (Open Access) -
Molekulare und klinische Charakterisierung von BRAF/NRAS/NF1-wt Melanomen
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21DOI (Open Access) -
Pathogenic autoantibody of scurfy mice recognizes unknown AIBD-related antigen with a molecular weight of 93 kDaIn: Experimental Dermatology. Hoboken: Wiley, Jg. 32, 2023, Nr. 4, S. e80
-
Untersuchung des klinischen Verlaufs von Melanompatienten mit einer Super-Response (CR/PR innerhalb von 3 Monaten) unter PD-1-basierter Immuncheckpoint-Inhibition : eine Subgruppen-Analyse der prospektiven multizentrischen Studie ADOREG
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 8 – 9DOI (Open Access) -
Cold atmospheric plasma versus diclofenac 3% gel in patients with actinic keratosesIn: Experimental Dermatology. Hoboken: Wiley, Jg. 31, 2022, Nr. 2, S. e24 – e24
-
Etablierung eines Deep-Learning-Algorithmus zur Differenzierung von Morbus Bowen und seborrhoischen Keratosen
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 15 -
Identification of bullous pemphigoid (BP) patients with sole IgG-reactivity against BP230 strongly indicates that autoantibodies against intracellular BP230 contribute to skin damage in BPIn: Experimental Dermatology. Hoboken: Wiley, Jg. 31, 2022, Nr. 2, S. e62
-
Klinische und pathologische Merkmale des familiären Melanoms bei Keimbahn-TERT-Promotorvarianten
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 6 -
012 Pathogenic murine anti-BP230 autoantibody 20B12 : Elucidating the mechanism of blister formation
50th Annual ESDR Meeting; 22-25 September 202; Virtual,In: Journal of Investigative Dermatology. Amsterdam: Elsevier, Jg. 141, 2021, Nr. 10, Supplement, S. S150DOI (Open Access) -
Absence of functional Treg in scurfy mice leads to pathogenic autoantibody targeting Type VII collagenIn: European Journal of Immunology. Hoboken: Wiley, Jg. 51, 2021, Nr. Suppl. 1
-
Absence of functional Tregs in scurfy mice leads to blister inducing autoantibody directed against Type VII Collagen
47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Virtual, March 04‐06, 2021,In: Experimental Dermatology. Hoboken: Wiley, Jg. 30, 2021, Nr. 3, S. E53 -
PD-L1-Expression and Mutation Profile in pre-therapeutic Tumor Tissue as Predictors of the Therapeutic Success of PD-1-based Immune Checkpoint Inhibition Therapy in Patients with metastatic Melanoma : Evaluation of the prospective multicentric ADO-Study TRIMIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 19
-
Predictors of Super-response (CR/PR within 3 Months) under PD-1-based Immune Checkpoint Inhibition in metastatic Melanoma : A Subgroup Analysis of the prospective multicenter Study ADOREG TRIMIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 6 – 7
-
TERT Promoter Mutations associated with longer progression-free and Overall Survival under BRAF/MEK TherapyIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 31
-
Tumor PD-L1 expression and gene panel mutational profile as outcome predictors of PD-1-based checkpoint inhibition therapy in metastatic melanoma : A prospective multicenter DeCOG studyIn: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 15_Suppl, S. 9568 – 9568DOI (Open Access)
-
Tumor PD-L1-Positivity in medical and digital Quantification predicts a favorable Patient Outcome for a PD-1-based Immune Checkpoint-Blockade in metastatic MelanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 58 – 59
-
Apoptotische Gastritis nach Immuncheckpointblockade : Ein typisches histopathologisches MusterIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P12DOI (Open Access)
-
Die digitale Analyse der Tumor PD‐L1 Expression ist ein guter Prädiktor des Therapieerfolgs einer anti‐PD1‐basierten Immuntherapie : Eine Subgruppenanalyse der multizentrischen translationalen Studie ADOREG/TRIMIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV36DOI (Open Access)
-
Eindrucksvolles und schnelles Therapieansprechen eines metastasierten Adnexkarzinoms unter CemiplimabIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV08DOI (Open Access)
-
Angiosarkom im Bereich des Capillitium mit der Symptomatik eines Quincke‐Ödems
28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. Suppl. 6, S. 34DOI (Open Access) -
Auswirkungen der überarbeiteten AJCC‐Klassifikation (8. Edition) auf das Essener Melanomkollektiv
28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 61 – 62DOI (Open Access) -
Clear Cell Sarcoma - a rare Differential Diagnosis of malignant MelanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. Suppl. 6, S. 3
-
Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE
45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,In: Experimental Dermatology. Hoboken: Wiley, Jg. 27, 2018, Nr. 3, S. e68 – e69DOI (Open Access) -
Klarzellsarkom – eine seltene Differentialdiagnose des malignen Melanoms
28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 3DOI (Open Access) -
Partielle Remission eines fortgeschrittenen Melanoms durch eine Kombinationstherapie mit Nivolumab und Trametinib nach Therapieversagen unter Ipilimumab + Nivolumab
28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 38DOI (Open Access) -
Phänotyp, Dichte und mikroanatomisches Verteilungsmuster von Immunzellen in kutanen Plattenepithelkarzinomen und umgebender Haut von immunsupprimierten, organtransplantierten und immunkompetenten Patienten
DDG Kompakt & Praxisnah ; 02.-03. März 2018, Stuttgart,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S1, S. 5DOI (Open Access) -
Therapieversagen der Immuncheckpoint‐Blockade mit PD1‐Antikörpern bei Patienten mit metastasierten Hauttumorerkrankungen und gleichzeitiger Immunsuppression durch eine Chronisch Lymphatische Leukämie
28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 16, 2018, Nr. S6, S. 28DOI (Open Access) -
High-resolution 3-D imaging for precise staging in malignant melanomaNew York, 2020DOI, Online Volltext (Open Access)
-
Ausgedehntes Rezidiv eines atypischen Fibroxanthoms
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO-Jahrestagung) 06.–09. September 2023 Hamburg, S. 99DOI (Open Access) -
Therapieansprechen auf Sunitinib bei Imatinib-resistentem Rezidiv eines Dermatofibrosarkoma protuberans am Capillitium
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 21, 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 99 – 100DOI (Open Access) -
Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S695 -
Genetic and methylation analysis of CTNNB1 mutations in benign and malignant melanocytic lesions
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 84 -
Molekularpathologie und Methylierungsprofile als diagnostische Unterstützung zur Differenzierung von Klarzellsarkomen und melanozytären Tumoren
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 88 -
3D data related to : Identification and quantification of hidden melanoma metastases in human sentinel lymph nodes using light sheet fluorescence microscopy2020DOI, Online Volltext (Open Access)